TP53 and ovarian cancer: Previously, our lab discovered that metastatic ascites cells (28–2) from our orthotopic, syngeneic murine model of ovarian cancer were p53 mutant, compared to p53 wild-type ID8 cells used for tumor induction [6], suggesting interaction with the ovarian microenvironment initiated the development of a TP53 mutation.